INTERCEPT PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • Intercept Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.7M, a 22.7% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $7.7M, a 2.53% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $7.9M, a 5.33% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.7M -$500K -22.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $2.2M +$400K +22.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $1.8M -$100K -5.26% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $1.9M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.